HEXO Corp (HEXO) disappoints in Q3
Late on Wednesday, HEXO Corp (TSX: HEXO; NYSE-A: HEXO) reported a basic net loss per share that widened to CAD...
Health Care
Neptune Wellness posts wider losses in Q4, shares fall
Canadian producer of wellness products, Neptune Wellness Solutions (NASDAQ: NEPT), said its revenues fell 16% in the first quarter to...
Catalent stock soars to record high
Catalent Inc. (CTLT) stock soared to a record high of $50.62 on Wednesday as investors were satisfied with the company’s...
Summit Therapeutics reports loss of $0.04 per share for Q1
Summit Therapeutics (NASDAQ: SMMT) reported a narrower-than-expected loss for the first quarter of 2019 while revenues missed estimates. The stock...
CymaBay Therapeutics stock drops to 2-year low after bitter NASH study data
CymaBay Therapeutics (NASDAQ: CBAY) stock fell to a two-year low of $4.82 on Tuesday after disappointing nonalcoholic steatohepatitis (NASH) trial...
Advaxis’ revenue declines in Q2 as Amgen terminaties collaboration agreement
Advaxis (NASDAQ: ADXS) reported that Q2 revenue decreased to $1.2 million from $1.7 million in the prior year quarter. The...
Earnings preview: Advaxis stock treading near an all-time low ahead of Q2 results
Late-stage biotech firm Advaxis, Inc. (NASDAQ: ADXS) is scheduled to report second-quarter financial results on June 10, Monday, after the...
Tilray stock heads downward on doubts of cannabis risks
Tilray (NASDAQ: TLRY) stock has fallen over 47% in the year so far. The stock has been on a downward...
What’s in store for top pharma stocks this year
The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note,...
CVS’ stock gains as company lays out growth strategy
CVS Health’s (NYSE: CVS) shares were up 3.2% in afternoon hours as the company outlined its growth strategy and reaffirmed...
WeedMD posts wider loss in Q1 but revenue soars 192%
Medical-grade cannabis producer WeedMD Inc. reported a wider loss in the first quarter of 2019 due to higher costs and...
Veeva Systems reports stellar Q1 earnings, outlook beat estimates
Veeva Systems (NYSE: VEEV) reported yet another solid earnings beating analyst estimates. The company also raised its full-year outlook and...
Looming opioid epidemic calls for stricter drug regulation
Though the healthcare industry is slowly waking up to the hazards of opioid-based prescription drugs, their sale continues unabated across...
Soliton spikes over 50% on its decision to proceed with cellulite trials
Shares of Soliton Inc. (NASDAQ: SOLY) jumped over 50% during the morning trade on Wednesday after the medical device company...
Charlotte’s Web Holdings retains full-year outlook; to delist from CSE
Charlotte’s Web Holdings (CSE: CWEB; OTCQX: CWBHF) first-quarter results came in line with the preliminary guidance provided earlier this month....
Earnings Preview: Charlotte’s Web to report solid Q1 results aided by multiple tailwinds
Charlotte’s Web Holdings (CSE: CWEB; OTCQX: CWBHF) is planning to report its first-quarter results tomorrow after the bell. The company...
Novartis’ one-time gene therapy for spinal muscular atrophy gets FDA nod
Zolgensma, a gene-based treatment from Novartis (NYSE: NVS) for the treatment of spinal muscular atrophy that affects newborns, received approval...
Centene stock spikes as activist investor Third Point pushes for its sale
Shares of Centene Corp (NYSE: CNC) shot up over 3% on average volume on Friday, after it was revealed that...
Medtronic tops expectations on Q4 results
Medtronic plc (NYSE: MDT) reported revenue and earnings for the fourth quarter of 2019 that topped market expectations. Shares rose...
Affimed’s stock tanks as company announces termination of cancer program
Affimed NV (NASDAQ: AFMD) reported first-quarter 2019 earnings results and announced its plans to terminate its cancer program while focusing...
Canopy Growth names Constellation Brands veteran as acting CFO
Shares of Canopy Growth Corporation (NYSE: CGC) gained over 2% on Tuesday after the cannabis giant announced the appointed of...